Texas 2009 - 81st Regular

Texas Senate Bill SB1416 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 81R7759 PB-F
22 By: Hegar S.B. No. 1416
33
44
55 A BILL TO BE ENTITLED
66 AN ACT
77 relating to certain contracts between pharmacy benefit managers and
88 the Employees Retirement System of Texas, the Teacher Retirement
99 System of Texas, The Texas A&M University System, or The University
1010 of Texas System.
1111 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1212 SECTION 1. Subchapter B, Chapter 1551, Insurance Code, is
1313 amended by adding Section 1551.067 to read as follows:
1414 Sec. 1551.067. PHARMACY BENEFIT MANAGER CONTRACTS. (a) In
1515 awarding a contract to provide pharmacy benefit manager services
1616 under this chapter the board of trustees is not required to select
1717 the lowest bid, but must select a contract that meets the criteria
1818 established by this section.
1919 (b) The contract must state whether the pharmacy benefit
2020 manager may or may not engage in therapeutic interchange by
2121 substituting a prescription drug with a different prescription drug
2222 preferred by the pharmacy benefit manager. If the contract
2323 authorizes therapeutic interchange as described by this
2424 subsection, the contract must provide that the pharmacy benefit
2525 manager shall maintain documentation of each instance in which
2626 therapeutic interchange is used.
2727 (c) The contract must state that the pharmacy benefit
2828 manager shall disclose in writing the financial and medical reasons
2929 for the addition, removal, or change in placement of a prescription
3030 drug from the drug formulary used by the pharmacy benefit manager.
3131 The disclosure required by this subsection must be made not later
3232 than the 30th day before the date that the addition, removal, or
3333 change in placement becomes effective.
3434 (d) The contract must identify the specialty drugs on the
3535 drug formulary used by the pharmacy benefit manager and state the
3636 specialty drug's associated costs, discounts, and other fees that
3737 apply to the pharmacy benefit manager's services performed under
3838 the contract.
3939 (e) The contract must disclose any policy, practice, or
4040 business relationship of the pharmacy benefit manager that could
4141 conflict with the performance of the pharmacy benefit manager's
4242 duties under the contract.
4343 (f) The contract must describe cost savings initiatives
4444 used by the pharmacy benefit manager, including the methodology and
4545 data used to compute any rebate amount that the board of trustees
4646 receives from the pharmacy benefit manager.
4747 (g) The contract must include a statement defining the
4848 maximum allowable cost, or MAC, price list to be used by the
4949 pharmacy benefit manager in performing the contract.
5050 (h) The contract must identify and label the specific
5151 information contained in the contract that is considered
5252 proprietary information belonging to the pharmacy benefit manager.
5353 (i) The contract must state whether the pharmacy benefit
5454 manager has a revenue-sharing agreement concerning the sale of data
5555 related to the services performed under the contract or whether the
5656 data can be sold by the pharmacy benefit manager. If data may be
5757 sold, the contract must:
5858 (1) disclose the conditions under which the pharmacy
5959 benefit manager may sell the data; and
6060 (2) state that the pharmacy benefit manager may not
6161 disclose any data in connection with the sale of the data before the
6262 30th day after the date the pharmacy benefit manager has provided
6363 written notice of that sale to the board of trustees.
6464 (j) The contract must state that:
6565 (1) the board of trustees is entitled to audit the
6666 pharmacy benefit manager to verify costs and discounts associated
6767 with drug claims, pharmacy benefit manager compliance with contract
6868 requirements, and services provided by subcontractors;
6969 (2) the audit must be conducted by an independent
7070 auditor in accordance with established auditing standards; and
7171 (3) to conduct the audit, the board of trustees and the
7272 independent auditor are entitled access to information related to
7373 the services and the costs associated with the services performed
7474 under the contract, including access to the pharmacy benefit
7575 manager's facilities, records, contracts, medical records, and
7676 agreements with subcontractors.
7777 (k) The contract must define the information that the
7878 pharmacy benefit manager is required to provide to the board of
7979 trustees concerning the audit of the retail, independent, and mail
8080 order pharmacies performing services under the contract and
8181 describe how the results of these audits must be reported to the
8282 board of trustees, including how often the results must be
8383 reported. The contract must state whether the pharmacy benefit
8484 manager is required to return recovered overpayments to the board
8585 of trustees.
8686 (l) The contract must state that any audit of a mail order
8787 pharmacy owned by the pharmacy benefit manager must be conducted by
8888 an independent auditor selected by the board of trustees in
8989 accordance with established auditing standards.
9090 SECTION 2. Subchapter C, Chapter 1575, Insurance Code, is
9191 amended by adding Section 1575.110 to read as follows:
9292 Sec. 1575.110. PHARMACY BENEFIT MANAGER CONTRACTS. (a) In
9393 awarding a contract to provide pharmacy benefit manager services
9494 under this chapter the trustee is not required to select the lowest
9595 bid, but must select a contract that meets the criteria established
9696 by this section.
9797 (b) The contract must state whether the pharmacy benefit
9898 manager may or may not engage in therapeutic interchange by
9999 substituting a prescription drug with a different prescription drug
100100 preferred by the pharmacy benefit manager. If the contract
101101 authorizes therapeutic interchange as described by this
102102 subsection, the contract must provide that the pharmacy benefit
103103 manager shall maintain documentation of each instance in which
104104 therapeutic interchange is used.
105105 (c) The contract must state that the pharmacy benefit
106106 manager shall disclose in writing the financial and medical reasons
107107 for the addition, removal, or change in placement of a prescription
108108 drug from the drug formulary used by the pharmacy benefit manager.
109109 The disclosure required by this subsection must be made not later
110110 than the 30th day before the date that the addition, removal, or
111111 change in placement becomes effective.
112112 (d) The contract must identify the specialty drugs on the
113113 drug formulary used by the pharmacy benefit manager and state the
114114 specialty drug's associated costs, discounts, and other fees that
115115 apply to the pharmacy benefit manager's services performed under
116116 the contract.
117117 (e) The contract must disclose any policy, practice, or
118118 business relationship of the pharmacy benefit manager that could
119119 conflict with the performance of the pharmacy benefit manager's
120120 duties under the contract.
121121 (f) The contract must describe cost savings initiatives
122122 used by the pharmacy benefit manager, including the methodology and
123123 data used to compute any rebate amount that the trustee receives
124124 from the pharmacy benefit manager.
125125 (g) The contract must include a statement defining the
126126 maximum allowable cost, or MAC, price list to be used by the
127127 pharmacy benefit manager in performing the contract.
128128 (h) The contract must identify and label the specific
129129 information contained in the contract that is considered
130130 proprietary information belonging to the pharmacy benefit manager.
131131 (i) The contract must state whether the pharmacy benefit
132132 manager has a revenue-sharing agreement concerning the sale of data
133133 related to the services performed under the contract or whether the
134134 data can be sold by the pharmacy benefit manager. If data may be
135135 sold, the contract must:
136136 (1) disclose the conditions under which the pharmacy
137137 benefit manager may sell the data; and
138138 (2) state that the pharmacy benefit manager may not
139139 disclose any data in connection with the sale of the data before the
140140 30th day after the date the pharmacy benefit manager has provided
141141 written notice of that sale to the trustee.
142142 (j) The contract must state that:
143143 (1) the trustee is entitled to audit the pharmacy
144144 benefit manager to verify costs and discounts associated with drug
145145 claims, pharmacy benefit manager compliance with contract
146146 requirements, and services provided by subcontractors;
147147 (2) the audit must be conducted by an independent
148148 auditor in accordance with established auditing standards; and
149149 (3) to conduct the audit, the trustee and the
150150 independent auditor are entitled access to information related to
151151 the services and the costs associated with the services performed
152152 under the contract, including access to the pharmacy benefit
153153 manager's facilities, records, contracts, medical records, and
154154 agreements with subcontractors.
155155 (k) The contract must define the information that the
156156 pharmacy benefit manager is required to provide to the trustee
157157 concerning the audit of the retail, independent, and mail order
158158 pharmacies performing services under the contract and describe how
159159 the results of these audits must be reported to the trustee,
160160 including how often the results must be reported. The contract must
161161 state whether the pharmacy benefit manager is required to return
162162 recovered overpayments to the trustee.
163163 (l) The contract must state that any audit of a mail order
164164 pharmacy owned by the pharmacy benefit manager must be conducted by
165165 an independent auditor selected by the trustee in accordance with
166166 established auditing standards.
167167 SECTION 3. Subchapter B, Chapter 1601, Insurance Code, is
168168 amended by adding Section 1601.064 to read as follows:
169169 Sec. 1601.064. PHARMACY BENEFIT MANAGER CONTRACTS. (a) In
170170 awarding a contract to provide pharmacy benefit manager services
171171 under this chapter a system is not required to select the lowest
172172 bid, but must select a contract that meets the criteria established
173173 by this section.
174174 (b) The contract must state whether the pharmacy benefit
175175 manager may or may not engage in therapeutic interchange by
176176 substituting a prescription drug with a different prescription drug
177177 preferred by the pharmacy benefit manager. If the contract
178178 authorizes therapeutic interchange as described by this
179179 subsection, the contract must provide that the pharmacy benefit
180180 manager shall maintain documentation of each instance in which
181181 therapeutic interchange is used.
182182 (c) The contract must state that the pharmacy benefit
183183 manager shall disclose in writing the financial and medical reasons
184184 for the addition, removal, or change in placement of a prescription
185185 drug from the drug formulary used by the pharmacy benefit manager.
186186 The disclosure required by this subsection must be made not later
187187 than the 30th day before the date that the addition, removal, or
188188 change in placement becomes effective.
189189 (d) The contract must identify the specialty drugs on the
190190 drug formulary used by the pharmacy benefit manager and state the
191191 specialty drug's associated costs, discounts, and other fees that
192192 apply to the pharmacy benefit manager's services performed under
193193 the contract.
194194 (e) The contract must disclose any policy, practice, or
195195 business relationship of the pharmacy benefit manager that could
196196 conflict with the performance of the pharmacy benefit manager's
197197 duties under the contract.
198198 (f) The contract must describe cost savings initiatives
199199 used by the pharmacy benefit manager, including the methodology and
200200 data used to compute any rebate amount that the system receives from
201201 the pharmacy benefit manager.
202202 (g) The contract must include a statement defining the
203203 maximum allowable cost, or MAC, price list to be used by the
204204 pharmacy benefit manager in performing the contract.
205205 (h) The contract must identify and label the specific
206206 information contained in the contract that is considered
207207 proprietary information belonging to the pharmacy benefit manager.
208208 (i) The contract must state whether the pharmacy benefit
209209 manager has a revenue-sharing agreement concerning the sale of data
210210 related to the services performed under the contract or whether the
211211 data can be sold by the pharmacy benefit manager. If data may be
212212 sold, the contract must:
213213 (1) disclose the conditions under which the pharmacy
214214 benefit manager may sell the data; and
215215 (2) state that the pharmacy benefit manager may not
216216 disclose any data in connection with the sale of the data before the
217217 30th day after the date the pharmacy benefit manager has provided
218218 written notice of that sale to the system.
219219 (j) The contract must state that:
220220 (1) the system is entitled to audit the pharmacy
221221 benefit manager to verify costs and discounts associated with drug
222222 claims, pharmacy benefit manager compliance with contract
223223 requirements, and services provided by subcontractors;
224224 (2) the audit must be conducted by an independent
225225 auditor in accordance with established auditing standards; and
226226 (3) to conduct the audit, the system and the
227227 independent auditor are entitled access to information related to
228228 the services and the costs associated with the services performed
229229 under the contract, including access to the pharmacy benefit
230230 manager's facilities, records, contracts, medical records, and
231231 agreements with subcontractors.
232232 (k) The contract must define the information that the
233233 pharmacy benefit manager is required to provide to the system
234234 concerning the audit of the retail, independent, and mail order
235235 pharmacies performing services under the contract and describe how
236236 the results of these audits must be reported to the system,
237237 including how often the results must be reported. The contract must
238238 state whether the pharmacy benefit manager is required to return
239239 recovered overpayments to the system.
240240 (l) The contract must state that any audit of a mail order
241241 pharmacy owned by the pharmacy benefit manager must be conducted by
242242 an independent auditor selected by the system in accordance with
243243 established auditing standards.
244244 SECTION 4. The change in law made by this Act applies only
245245 to a contract with a pharmacy benefit manager executed or renewed on
246246 or after the effective date of this Act.
247247 SECTION 5. This Act takes effect September 1, 2009.